| Name | Title | Contact Details |
|---|
Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.
Huntington Medical Research Insitutes is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Richman Root Delaney MD is a Waterford, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Adelphi International Research is a Doylestown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Olympic Medical Corp is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.